Inventor · disambiguated record
Fabrice Pierre
Also filed as: PIERRE FABRICE · PIERRE FABRICE JEAN DENIS
33 granted patents·26 pending applications·314 citations·filing 2002–2024
97Inventor score
Top patents by PatentIndex Score
59 records- 0198US10793547B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Oct 6, 2020·24 cites·21 claims
- 0297US11591350B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Feb 28, 2023·7 cites·27 claims
- 0397US11584761B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Feb 21, 2023·9 cites·37 claims
- 0497US11453655B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2020·Granted Sep 27, 2022·8 cites·8 claims
- 0597US10758534B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Granted Sep 1, 2020·13 cites·38 claims
- 0697US10258624B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·32 cites·47 claims
- 0797US9782408B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·33 cites·84 claims
- 0896US11873300B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Jan 16, 2024·6 cites·25 claims
- 0996US11426407B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Aug 30, 2022·6 cites·47 claims
- 1096US10570115B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Feb 25, 2020·23 cites·18 claims
- 1195US11066417B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2019·Granted Jul 20, 2021·13 cites·47 claims
- 1295US7928100B2Quinolone analogs and methods related theretoCYLENE PHARMACEUTICALS INC·Filed 2008·Granted Apr 19, 2011·23 cites·2 claims
- 1394US11866450B2Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·3 cites·41 claims
- 1493US12168009B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Dec 17, 2024·1 cites·46 claims
- 1593US12122788B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Oct 22, 2024·1 cites·21 claims
- 1693US11414439B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Aug 16, 2022·6 cites·31 claims
- 1792US11186566B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Nov 30, 2021·10 cites·10 claims
- 1891US7816406B2Quinolone analogsCYLENE PHARMACEUTICALS INC·Filed 2005·Granted Oct 19, 2010·11 cites·17 claims
- 1988US7402579B2Quinobenzoxazine analogs and compositionsCYLENE PHARMACEUTICALS INC·Filed 2006·Granted Jul 22, 2008·11 cites·6 claims
- 2088US2025205232A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2187US7816524B2Methods of preparing quinolone analogsCYLENE PHARMACEUTICALS INC·Filed 2006·Granted Oct 19, 2010·10 cites·22 claims
- 2287US7652134B2Methods for converting quinolone esters into quinolone amidesCYLENE PHARMACEUTICALS INC·Filed 2005·Granted Jan 26, 2010·11 cites·29 claims
- 2386US8168651B2Protein kinase modulatorsCHUA PETER C·Filed 2009·Granted May 1, 2012·11 cites·11 claims
- 2485US12319693B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 2585US2025171469A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2684US8853234B2Quinolone analogs and methods related theretoNAGASAWA JOHNNY YASUO·Filed 2011·Granted Oct 7, 2014·13 cites·18 claims
- 2784US8575177B2Pyrazolopyrimidines and related heterocycles as CK2 inhibitorsHADDACH MUSTAPHA·Filed 2010·Granted Nov 5, 2013·12 cites·40 claims
- 2882US9303033B2Pyrazolopyrimidines and related heterocycles as CK2 inhibitorsSENHWA BIOSCIENCES INC·Filed 2013·Granted Apr 5, 2016·6 cites·44 claims
- 2982US9062043B2Fused tricyclic compounds as serine-threonine protein kinase and PARP modulatorsCHUA PETER C·Filed 2011·Granted Jun 23, 2015·7 cites·25 claims
- 3081US12384762B2Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 3179US7834180B2Methods of preparing quinolone analogsCYLENE PHARMACEUTICALS INC·Filed 2008·Granted Nov 16, 2010·3 cites·22 claims
- 3278US2024368189A1Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the ModulatorsVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3376US2023312616A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3471US2022306606A1Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3567US2021139514A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 3664US2025340574A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3763US7652044B2P-38 inhibitorsNOVARTIS AG·Filed 2004·Granted Jan 26, 2010·1 cites·46 claims
- 3863US2009215761A1Quinobenzoxazine analogs and methods of using thereofCYLENE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3960US2010004298A1P-38 inhibitorsDONG QING·Filed 2009·Application pending·0 cites
- 4056US2023382924A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4156US2023382925A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4256US2023365587A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4356US2024018161A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4456US2023374038A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4556US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4653US2022047564A1Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 4751US7910600B2Therapeutic kinase modulatorsCYLENE PHARMACEUTICALS INC·Filed 2008·Granted Mar 22, 2011·0 cites·17 claims
- 4850US2022313698A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 4947US2011112086A1Pyridinone analogsCYLENE PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 5047US2005042674A9Common ligand mimics: thiazolidinediones and rhodaninesFiled 2002·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Fabrice Pierre files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →